CONLEY SHERYL L 4

What Happened

• Sheryl L. Conley, a director of Neuronetics, received a grant of 30,000 restricted stock units (RSUs) on May 28, 2026. The grant was recorded at $0.00 per unit (no cash exchanged at grant). RSUs are a form of equity compensation, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-28; filing date: 2026-05-29 (timely filing).
• Grant: 30,000 RSUs @ $0.00; total cash paid at grant = $0.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote highlights:
  • F1: RSUs vest on the earlier of (a) May 28, 2027 or (b) the Reporting Person’s Board-approved separation of service from the issuer or a change in control, subject to continuous service through such date.
  • F2: Each RSU represents a contingent right to receive one share of common stock upon vesting.
• Transaction code: A = Award/Grant.

Context

• RSUs are a deferred compensation award that convert to shares only if vesting conditions are met; they can be forfeited if service requirements aren’t satisfied. Because this is an award rather than a purchase or sale, it is generally a routine compensation event and does not, by itself, indicate the insider’s view on the company’s stock price.